Showing 6181-6190 of 20929 results for "".
- Genomic Tools Enhance Prognostic Precision in Multiple Myelomahttps://reachmd.com/news/genomic-tools-enhance-prognostic-precision-in-multiple-myeloma/2474845/Oncologists and hematologists are increasingly utilizing genomic tools to manage multiple myeloma, a complex hematologic malignancy where traditional prognostic methods, such as
- Radiation Dose Reduction in Diagnostic Cerebral Angiography: A Novel Filter Techniquehttps://reachmd.com/news/radiation-dose-reduction-in-diagnostic-cerebral-angiography-a-novel-filter-technique/2474875/At the intersection of patient safety and technological advancement, recent findings confirm that redesigned filter technology in diagnostic cerebral angiography effectively reduces radiation exposure to the eye lens while maintaining image excellence.
- Study: Most Global Melanoma Cases Attributable to UV Exposurehttps://reachmd.com/news/study-most-global-melanoma-cases-attributable-to-uv-exposure/2474874/A new global analysis of cutaneous melanoma (CM) shows ultraviolet radiation (UVR) as the primary driver behind the majority of CM cases worldwide in 2022. Researchers used updated incidence estimates from GLOBOCAN 2022 (exclud
- Biologic Therapies Redefining Atopic Dermatitis Managementhttps://reachmd.com/news/biologic-therapies-redefining-atopic-dermatitis-management/2474885/Despite improved understanding of atopic dermatitis pathophysiology, a significant subset of patients continues to experience poorly controlled disease under conventional therapies, highlighting the urgent need for targeted biologic solutions
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://reachmd.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2475371/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more
- Deep Brain Stimulation and Exercise: A Paradigm Shift in Parkinson's Managementhttps://reachmd.com/news/deep-brain-stimulation-and-exercise-a-paradigm-shift-in-parkinsons-management/2474878/With tremors and rigidity often persisting despite optimized pharmacotherapy, Parkinson’s disease treatment continues to fall short, prompting exploration of deep brain stimulation as a promising approach for improving motor function.
- ADA: Dermatologists Need to Lead on Climate Healthhttps://reachmd.com/news/ada-dermatologists-need-to-lead-on-climate-health/2474867/The American Dermatological Association (ADA) has issued its first comprehensive policy statement on climate change, publishing the document in the Journal of Investigative Dermatology.
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://reachmd.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2474873/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more than thre
- Predictive Analytics in Neurosurgery: Revolutionizing Postoperative Monitoringhttps://reachmd.com/news/predictive-analytics-in-neurosurgery-revolutionizing-postoperative-monitoring/2474890/Recent validation studies demonstrate that predictive analytics, such as a tailored prediction score for elective craniotomies, can reduce unplanned ICU admissions and
- Revance Announces CEO Transitionhttps://reachmd.com/news/revance-announces-ceo-transition/2475370/Revance announced a leadership transition last week as part of a long-term succession strategy following its integration with Crown Laboratories, according to a news release from the company. Founder and CEO of Crown Laboratories Jeff Bedard will assume the role of Executive Chai